These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36240903)

  • 1. Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
    Kaplan J; Turok DK; Gero A; Kaiser JE; Simmons RG; Fay KE
    Contraception; 2023 Feb; 118():109893. PubMed ID: 36240903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
    Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
    Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.
    Kaiser JE; Turok DK; Gero A; Gawron LM; Simmons RG; Sanders JN
    Am J Obstet Gynecol; 2023 Apr; 228(4):438.e1-438.e10. PubMed ID: 36427600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
    Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
    Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K
    Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
    Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
    Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
    Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
    Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
    Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm
    Perelló-Capó J; Estadella-Tarriel J; Gich-Saladich I; Bailón-Queiruga M; Llurba-Olivé E; Calaf-Alsina J
    Contraception; 2024 May; 133():110367. PubMed ID: 38232939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    Todd CS; Jones HE; Langwenya N; Hoover DR; Chen PL; Petro G; Myer L
    PLoS Med; 2020 May; 17(5):e1003110. PubMed ID: 32442189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm
    Perelló-Capó J; Estadella-Tarriel J; Gich-Saladich I; Bailón-Queiruga M; Llurba-Olivé E; Calaf-Alsina J
    Contraception; 2023 Nov; 127():110127. PubMed ID: 37487868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for emergency contraception.
    Shen J; Che Y; Showell E; Chen K; Cheng L
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001324. PubMed ID: 30661244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.